Pyxis Oncology (PYXS) Enterprise Value (QoQ) (2021 - 2025)
Pyxis Oncology (PYXS) Enterprise Value (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pyxis Oncology | 166.54 Mn | 99.69 Mn | 8.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.33% |
| Sep 30, 2025 | -524.79% |
| Jun 30, 2025 | 14.24% |
| Mar 31, 2025 | 88.79% |
| Dec 31, 2024 | 12.35% |
| Sep 30, 2024 | -445.54% |
| Jun 30, 2024 | 9.83% |
| Mar 31, 2024 | 75.32% |
| Dec 31, 2023 | 10.28% |
| Sep 30, 2023 | -385.81% |
| Jun 30, 2023 | 49.81% |
| Mar 31, 2023 | 69.83% |
| Dec 31, 2022 | 9.62% |
| Sep 30, 2022 | 11.04% |
| Jun 30, 2022 | 9.55% |
| Mar 31, 2022 | 10.01% |
| Dec 31, 2021 | -106.93% |
| Sep 30, 2021 | 6.31% |
| Jun 30, 2021 | -1.29% |